Abstract Chinese rhesus macaques are of particular interest in simian immunodeficiency virus/human immunodeficiency
Introduction
Indian-origin rhesus macaques and Chinese-origin rhesus macaques have not only been both utilized extensively in simian immunodeficiency virus/human immunodeficiency virus (SIV/HIV) research, but also as models for other pathogens (Campillo-Gimenez et al. 2010; Chen et al. 2011; Gardner and Luciw 2008; Giraldo-Vela et al. 2008; Hu et al. 2005; Joag et al. 1994; Kanthaswamy et al. 2009a, b; Ling et al. 2002; Miller et al. 1989; Wambua et al. 2011; Xia et al. 2010) . While these two sets of animals appear to be indistinguishable physiologically, Chinese rhesus macaques have a much more prolonged progression to acquired immunodeficiency syndrome (AIDS) as compared to Indian rhesus macaques (Campillo-Gimenez et al. 2010; Hu et al. 2005; Ling et al. 2002; Xia et al. 2010) . The mechanism for these differential outcomes has not been deciphered, but may be related to differences in the cellular immune response and the host genetics that influence their development. Recent studies have shown that the major histocompatibility complex (MHC) gene regions of Indian and Chinese macaques differ appreciably in terms of the degree of polymorphism, the specific allelic variants, and their functional characteristics (Li et al. 2012; Maness et al. 2011; Ouyang et al. 2008 Ouyang et al. , 2009 Solomon et al. 2010; Southwood et al. 2011; Wambua et al. 2011; Wiseman et al. 2009 ). This is particularly relevant in terms of MHC class I molecules, which determine the repertoire of CD8 + T cell responses that an individual can develop against SIV and/or any other foreign pathogen (Parham 2005) .
A number of studies have detailed the specificity of MHC class I molecules expressed in Indian macaques (Allen et al. 2001; Chen et al. 1992; Dzuris et al. 2000; Giraldo-Vela et al. 2008; Kuroda et al. 1998; Letvin et al. 1993; Loffredo et al. 2004 Loffredo et al. , 2007c Miller et al. 1991; Mothe et al. 2002a, b; Pal et al. 2002; Reed et al. 2011; Sette et al. 2005; Sidney et al. 2000) . It is of relevance to note that not all disease protection or susceptibility studies have been linked to MHC genes, but in specific instances, MHC class I alleles have been shown to be associated with disease progression, or to nonprogression, to AIDS in HIV/SIV infections. In particular, recent studies have shown that Mamu-B*003:01, a relatively infrequent allele in Indian rhesus macaques, but expressed in Chinese rhesus macaques at a frequency of 5.8 % (Kaizu et al. 2007; Solomon et al. 2010) , has a peptide-binding repertoire analogous to that of the human MHC class I molecule HLA-B*27:05 (Loffredo et al. 2009 ). Strikingly, the Mamu-B*003:01 allele has a protective effect in the context of SIV infection of Indian rhesus macaques that parallels the protective effect of its human counterpart in HIV infection (Loffredo et al. 2007b (Loffredo et al. , c, 2008 (Loffredo et al. , 2009 ). Mamu-B*008:01, present in Indian rhesus macaques, also has a binding repertoire similar to HLA-B*27:05 (Loffredo et al. 2009 ). Several studies have shown a protective effect in Mamu-B*008:01-expressing animals in the context of SIV infection in Indian rhesus macaques in terms of a delayed progression to AIDS and superior viral control (Loffredo et al. 2007a (Loffredo et al. , b, 2008 . Most recently, it has been shown that CD8 + T cell responses can be specifically attributed to protection in the context of SIV infection in Mamu-B*008:01-positive animals (Mudd et al. 2012) . Other MHC class I alleles, such as HLA-B*57 (Chen et al. 2012) , have also been implicated in delayed progression to AIDS and, therefore, should not be ignored.
In this context, it would be insightful to understand the role of other MHC class I alleles expressed in nonhuman primate animal models that have alleles that are HLA-B27-like, as well as animals possessing other HLA-like alleles. For this to be possible, further investigation and characterization of the MHC class I alleles most commonly expressed in other models, such as Chinese macaques, is necessary. These types of studies will allow better realization of the potential of Chinese-origin macaques to facilitate infectious disease research and perhaps yield a better understanding of the differences between Indian and Chinese macaques in terms of outcomes of SIV infection. Since no specific MHC class I allele is present in the Chinese population at a frequency >9 % (Solomon et al. 2010) , the characterization of several MHC class I molecules is needed to understand the complexity of immune responses in these animals.
We have recently elucidated peptide-binding motifs for four common Chinese macaque MHC class I molecules: Mamu-B*039:01 (Sette et al. 2012) , Mamu-A1*026:01, Mamu-B*083:01 (Southwood et al. 2011) , and Mamu-A1*022:01 (Solomon et al. 2010) . Interestingly, the motifs for three of these alleles were found to overlap with those associated with HLA class I supertypes, which describe sets of HLA class I alleles grouped together on the basis of shared main peptide-binding specificity (i.e., the supermotif) (see, e.g., Lund et al. 2004; Sette and Sidney 1999; Sidney et al. 1995 Sidney et al. , 1996 Sidney et al. , 2008 . Specifically, the Mamu-A1*026:01 motif overlaps with that of the HLA-A2 supertype, Mamu-B*083:01 with the HLA-A3 supertype (Southwood et al. 2011) , and Mamu-A1*022:01 with the HLA-B7 supertype (Solomon et al. 2010) . The HLA-B7, HLA-A3, and HLA-A2 supertypes are the three most abundant supertypes in the human population, each present with a phenotypic frequency of >40 %, averaged across various ethnic groups (Lund et al. 2004; Sette and Sidney 1999; Sidney et al. 1995 Sidney et al. , 2008 .
In this study, we have characterized a set of six additional alleles that were the next most commonly expressed MHC class I alleles in rhesus macaques of Chinese origin. Strikingly, we found that the motifs associated with all of the new alleles are also analogous to those of various common HLA alleles. In particular, we found that two of these alleles are associated with HLA-B27-like peptide-binding motifs. We were interested in developing these motifs to provide additional resources to facilitate future research towards an understanding of the role of MHC class I alleles and specific responses in the context of infection.
Materials and methods

Creation of stable Mamu transfectant lines
Stable MHC class I transfectants were produced in the MHC class I-deficient EBV-transformed B-lymphoblastoid cell line 721.221. An expression construct was created for each Chinese rhesus macaque MHC class I allele by subcloning a full-length allele transcript into separate pcDNA 3.1 vectors (Invitrogen). These constructs were then used to transfect MHC class I-null 721.221 cells using an Amaxa Nucleofector II transfection instrument (Lonza AG, Walkersville, MD, USA). Each construct was transfected using the specific G-016 program on the Nucleofector II instrument. For each transfection, 1×10 7 721.221 cells were mixed with 15 μg of DNA using the Amaxa Nucleofector Solution C (Lonza AG, Walkersville, MD, USA).
Elution of naturally bound ligands from common Chinese MHC class I molecules
The 721.221 cell lines transfected with a single macaque MHC class I allele were expanded and harvested to generate a pellet equivalent to approximately 5×10 9 cells. Cell pellets were lysed for 30 min in a buffer containing 150 mM NaCl, 20 mM Tris-HCl (pH 8.0), and 1 % CHAPS (Sigma) and a cocktail of protease inhibitors that included 5 μg/ml aprotinin (Sigma), 10 μg/ml leupeptin (Sigma), 10 μg/ml pepstatin A (EMD Millipore), 1 mM phenylmethanesulfonyl fluoride (Fisher), phosphatase inhibitor cocktail I (Fisher), phosphatase inhibitor cocktail II (Sigma), and 10 nM calyculin A (Sigma). The lysate was centrifuged for 1 h at 100,000×g (SW28 rotor at 27,500 rpm). The supernatant containing soluble proteins was decanted and filtered through an Acrodisc PF 0.2 μM syringe filter with 0.8 μM prefilter (Fisher), retaining the filtrate.
The filtrate was passed over, in series, a Sepharose CL-4B precolumn, an irrelevant MHC class I antibody affinity column to assess nonspecific binding (antimouse MHC class I MKD6, in this case), and then a W6/32 antibody (antiprimate MHC class I) affinity column to bind MHC class I molecules, as previously described (Sidney et al. 2001b) . Affinity columns were then separated and washed with 2 column volumes (cv) of lysis buffer, 20 cv of 20 mM Tris-HCl (pH 8.0), with 150 mM NaCl, 20 cv of 20 mM Tris-HCl (pH 8.0), with 1.0 M NaCl, and 20 cv of 20 mM Tris-HCl (pH 8.0).
Separately, each affinity column was eluted with 4 cv of 0.2 N acetic acid into a 50-ml conical vial, at which point glacial acetic acid was added to bring the final concentration to 10 % acetic acid. The acid eluate was transferred to the top reservoirs of preconditioned centrifugal filtration units with a molecular weight cutoff of 3,000 Da (Millipore). This threshold excludes β2-microglobulin from passing into the sample of endogenous ligands. The units were then centrifuged at 3,500×g for approximately 3 h, until the majority of the eluate had been filtered to the collection reservoir, with minimal retentate (∼200 μl) remaining.
The filtrate containing the soluble endogenous peptides was then aliquoted into Eppendorf Protein LoBind microcentrifuge tubes (Fisher) and concentrated using vacuum centrifugation. The sample aliquots were pooled and washed with 10 % acetic acid as volume decreased, ceasing the process when a final volume of ∼250 μl was achieved. The samples were stored at −80°C until analysis by tandem mass spectrometry (MS/MS) was performed.
Peptide sequence analysis by MS/MS Peptides were analyzed by nanoflow high-performance liquid chromatography (HPLC)/microelectrospray ionization, coupled directly to a Thermo Fisher Scientific Orbitrap or FT-ICR mass spectrometer, equipped with either a homebuilt, front-end electron transfer dissociation (FETD) source (Earley et al. 2010) or an Orbitrap Velos mass spectrometer equipped with a commercial ETD source.
Data were acquired as previously described (Udeshi et al. 2008 For the analyses, collisionally activated dissociation (CAD) and ETD fragmentation were performed sequentially on the same parent ions. The FETD reagent was azulene and the ion-ion reaction time was set to 30 ms, while fluoranthene was used with a 50-ms reaction time on the commercial source. The instrument was operated in a data-dependent mode where a full-scan mass spectrum was acquired with the high-resolution mass analyzer and this was then followed by sequential acquisition of CAD and ETD MS/MS spectra in the linear trap on the top 5, most abundant, non-excluded ions observed in the full-scan spectrum. Data from MS/MS experiments were searched against the Swiss-Prot (Bairoch and Apweiler 2000) human database using the Open Mass Spectrometry Search Algorithm software (Geer et al. 2004 ) to generate a list of candidate peptide sequences. Instrument parameters included a precursor mass tolerance of ±0.005 Da and a monoisotopic fragment ion mass tolerance of ±0.6 Da. Database search parameters allowed variable modifications for phosphorylation on serine, threonine, and tyrosine residues and oxidation of methionine. Database assignments were confirmed by manual interpretation of the corresponding MS/MS spectra and by showing that spectra recorded on synthetic peptides were identical to those obtained from the biological sample.
Positional scanning combinatorial library and peptide synthesis Positional scanning combinatorial libraries (PSCL) were synthesized as previously described (Pinilla et al. 1999 ). In the PCSL, each pool in the library contains randomized 9-mer peptides with one fixed residue at a single position. With each of the 20 naturally occurring residues represented at each position along a 9-mer backbone, the entire library consisted of 180 peptide mixtures.
Peptides utilized in screening studies were purchased as crude or purified material from Mimotopes (Minneapolis, MN, USA/Clayton, Victoria, Australia), Pepscan Systems B.V. (Lelystad, Netherlands), A&A Labs (San Diego, CA, USA), GenScript Corporation (Piscataway, NJ, USA), or the Biotechnology Center at the University of WisconsinMadison (Madison, WI, USA). Peptides synthesized for use as radiolabeled ligands were synthesized by A&A Labs and purified to >95 % homogeneity by reverse-phase HPLC. Peptide purity was determined with analytical reverse-phase HPLC and amino acid analysis, sequencing, and/or mass spectrometry. Peptides were radiolabeled utilizing the chloramine T method (Sidney et al. 2001a ). Lyophilized peptides were resuspended at 20 mg/ml in 100 % DMSO, then diluted to required concentrations in PBS+0.05 % (v/v) Nonidet P40 (Fluka Biochemika, Buchs, Switzerland). SIV peptide sequences were derived from the SIVmac239 sequence, GenBank accession M33262 (Kestler et al. 1990 ).
MHC purification and peptide-binding assays MHC class I purification was performed by affinity chromatography using the W6/32 class I antibody, as previously described (Allen et al. 2001; Loffredo et al. 2009; . Protein purity, concentration, and depletion efficiency steps were monitored by sodium dodecyl sulfate polyacrylamide gel electrophoresis.
Quantitative assays for peptide binding to detergentsolubilized MHC class I molecules were based on the inhibition of binding of a high-affinity radiolabeled standard probe peptide and performed as detailed in prior studies (Loffredo et al. 2009; Schneidewind et al. 2008; Sette et al. 2001; . Peptides were tested at six different concentrations covering a 100,000-fold dose range in three or more independent assays. For each peptide, the concentration of peptide yielding 50 % inhibition of the binding of the radiolabeled probe peptide (IC 50 (Gulukota et al. 1997; Sette et al. 1994b) . Control wells to measure nonspecific (background) binding were also included. In each experiment, a titration of the unlabeled version of the radiolabeled probe was also tested as a positive control for inhibition.
The radiolabeled peptides utilized for developing the peptide-binding assays that represent sequences identified by Edman degradation and mass spectrometry analysis (described previously), are presented in Supplemental Table 2 (in bold). For one allele, Mamu-A7*01:03, an analog of a natural ligand was synthesized (RAEDNADYL), in which a threonine substitution was made at position 8 (T→Y) to allow for iodine-125 radiolabeling. For the Mamu-B*090:01 assay, a ligand (sequence MSAPPAEYK) previously identified by direct binding assay, was utilized as the radiolabeled probe. The binding assay for Mamu-B*090:01 was, therefore, developed empirically prior to use, in our laboratory, of natural ligand elution methodologies as a means to identifying a ligand of interest.
Bioinformatic analysis
Analysis of the PSCL data was performed as described previously . Briefly, IC 50 nanomolar values for each mixture were standardized as a ratio to the geometric mean IC 50 nanomolar value of the entire set of 180 mixtures and then normalized at each position so that the value associated with optimal binding at each position corresponds to 1. For each position, an average (geometric) relative binding affinity (ARB) was calculated, and then the ratio of the ARB for the entire library to the ARB for each position was derived. We have denominated this ratio, which describes the factor by which the normalized geometric average binding affinity associated with all 20 residues at a specified position differs from that of the average affinity of the entire library, as the specificity factor (SF). As calculated, positions with the highest specificity will have the highest SF value. Primary anchor positions were then defined as those with an SF≥2.4. This criterion identifies positions where the majority of residues are associated with significant decreases in binding capacity.
Secondary anchor designations were based on the standard deviation (SD) of residue specific values at each position. Dominant secondary anchor positions were defined as those where SD>3 and SF<2.4, as well as positions associated with an SD>2 if the SF is between 1.5 and 2.4. Weak secondary anchors have been defined as positions associated with SD in the 2.5-3 range with SF<1.5 or with SF in the 1.5-2.4 range with SD<2.
To identify predicted binders, all possible 9-mer peptides in SIVmac239 sequences were scored using the matrix values derived from the PSCL analyses of the six Mamu alleles under investigation in this study . The final score for each peptide represents the product of the corresponding matrix values for each peptide residue-position pair. Peptides scoring among the top 3.0 % (n=100) were selected for binding analysis.
Results
Selection of a panel of MHC class I alleles commonly expressed in Chinese rhesus macaques
To identify the MHC class I alleles most frequently expressed in Chinese macaques, we previously sequenced alleles from a cohort of 50 Chinese rhesus macaques representing three colonies currently utilized in biomedical research: the Scripps Research Institute, the Tulane National Primate Research Center, and the Washington National Primate Research Center (Solomon et al. 2010) . Using data from that particular study, as well as MHC class I allele frequency information from other publications, a panel of the 12 most frequent alleles was generated (Solomon et al. 2010) . We have already characterized six of these most common molecules Loffredo et al. 2005; Sette et al. 2012; Solomon et al. 2010; Southwood et al. 2011) to include Mamu-A1*022:01, Mamu-A1*026:01, Mamu-B*083:01, Mamu-B*039:01, Mamu-B*003:01, and Mamu-B*001:01:02, which are present in both Indian and Chinese rhesus macaque populations.
In the present study, we have undertaken efforts to characterize the six next most common Chinese rhesus alleles (Mamu-A7*01:03, Mamu-B*066:01, Mamu-B*010:01, Mamu-B*087:01, Mamu-A2*01:02, and Mamu-B*090:01), thereby doubling the number of alleles characterized in this model (Table 1) . These six alleles range in phenotypic frequency from 6.1 % (Mamu-A7*01:03) to 2.2 % (Mamu-B*090:01). The combined phenotypic frequency of these six new alleles is 29 %, which, together with the six previously characterized alleles, brings the combined frequency of Chinese rhesus macaque MHC class I alleles studied to date to almost 60 % (Table 1) .
Establishment of a peptide-binding assay for Mamu-B*090:01 based on predicted overlap with HLA Mamu-B*090:01 MHC class I molecules expressed in single allele transfectants of the 721.221 cell line were purified by affinity chromatography as described in the "Materials and methods" section. As previously mentioned, previous studies demonstrated that HLA supertype ligands also bind to MHC molecules expressed in other species, such as chimpanzees (Pan troglodytes), mice (Mus musculus) (Bertoni et al. 1998; McKinney et al. 2000; Sette et al. 2005; Sidney et al. 2006) , and Chinese rhesus macaques (Solomon et al. 2010) .
Hierarchical clustering analysis (data not shown) predicted that Mamu-B*090:01 might be associated with an HLA-A3 supertypic peptide-binding specificity. Indeed, significant binding was detected using the HLA-A3 supertype ligand MSAPPAEYK with as little as 2.0 nM of purified MHC (Supplemental Fig. 1 ). This binding was specific in that it could be inhibited by unlabeled MSAPPAEYK with an IC 50 of approximately 1.1 nM ( Fig. 1 and Supplemental Table 1 ). The specificity of binding was further demonstrated by the fact that the same MHC preparation did not bind the VVMAYVGIK radiolabeled peptide, which is also a HLA-A3 supertype ligand.
Determination of natural ligands from common Chinese rhesus macaque MHC class I molecules
Previous studies have demonstrated that the elution and characterization of naturally bound ligands is an effective method for determining the peptide-binding specificity of MHC class I molecules Kubo et al. 1994) . Accordingly, naturally bound peptides were identified as described in the "Materials and methods" Table 2 ), respectively. The majority of ligands for both Mamu-A2*01:02 and Mamu-A7*01:03 were nine residues in length (Supplemental Table 2 ). Specifically, 14 of the 18 (78 %) ligands eluted from Mamu-A2*01:02 and 5 of the 6 (83 %) ligands eluted from Mamu-A7*01:03 were 9-mers. In addition, one Mamu-A2*01:02 ligand was an 8-mer, two where 10-mers, and another was 11 residues in length. For Mamu-A7*01:03, one additional identified ligand was 10 residues.
The lengths of endogenous peptides identified for the three Mamu-B alleles were more variable. For Mamu-B*010:01, peptides ranged in size from 8 to 12 residues, with just over half (17 of 30; 57 %) being nonamers. The next most frequent size was 11-mers, with six peptides identified (20 %). For Mamu-B*066:01, the most common peptide size was also 9 residues, with 6 of the 14 ligands being this length. Furthermore, 5 of 14 ligands were 10-mers, suggesting that peptides of both 9 and 10 peptide lengths are commonly bound. Mamu-B*087:01 also displayed ligands of variable sizes. In this case, 10-mers comprised the majority of the ligands (41 %; 11 of 27), although 9-mers, 12-mers, and 13-mers were all represented, with 6, 4, and 3 ligands each, respectively. Mamu-B*087:01 also bound a peptide 14 residues in length, but it did not bind 8-mer peptides (Supplemental Table 2 ).
Establishment of peptide-binding assays based on naturally processed ligands
We next sought to establish binding assays for the five Chinese MHC class I molecules for which naturally processed ligands were defined. MHC class I molecules were purified by affinity chromatography, and peptides corresponding to naturally bound ligands were synthesized. Peptides containing Y were radiolabeled, and their capacity to bind their associated purified MHC was investigated. For natural ligands in which a tyrosine was not present, Y substitutions were introduced by substitution at various traditionally non-main anchor positions.
For each allele, the peptide yielding the strongest signal counts per minute in direct binding assays was selected for further characterization. Those ligands were SHSHVGYTL for Mamu-A2*01:02, RAEDNADYL (T8→Y analog) for Mamu-A7*01:03, SHIDRVYTL for Mamu-B*010:01, YFAIAENESK for Mamu-B*066:01, and SDIDGDYRV for Mamu-B*087:01. In all cases, the binding was selective, as other radiolabeled peptides assayed displayed little to no binding (Supplemental Fig. 1) . Furthermore, the binding of each was specific at the level of inhibition by unlabeled ligands, with measured IC 50 values ranging from 200 pM to 2.0 nM ( Fig. 1 determined in inhibition assays, as described in the "Materials and methods" section. As shown, each peptide was tested at multiple doses over a 5 log range. The binding in each case was specific, as binding by the radiolabeled ligand could be inhibited by the unlabeled version of the respective probe peptide, but not by unrelated control ligands. IC 50 values for the reference peptides ranged from 500 pM to 2.0 nM, depending on the exact allele/ligand combination. Representative inhibition curves for each MHC class I molecule are shown
The identification of MHC/peptide-binding motifs for six common Chinese rhesus macaque class I molecules To define the peptide-binding motifs of the six alleles, we tested the capacity of 9-mer PSCL to bind purified MHC (Supplemental Table 3 ). The data were analyzed, and anchor positions were determined, following the criteria outlined in the "Materials and methods" section.
Mamu-B*087:01 was determined to have primary anchors at position 3 and the C terminus (Fig. 2) . Aspartic acid (D) is dominant at position 3, with F and S being tolerated. Interestingly, D is a preferred residue at a number of positions, including positions 2, 3, 5, 6, and 7. At the Cterminal primary anchor, a preference for the hydrophobic residues L, F, M, and I was found (and V was tolerated). Mamu-B*087:01 also has dominant secondary anchors at positions 7 and 8. Based on the described profile, the Mamu-B*087:01 motif (Fig. 2) closely resembles the motif associated with the HLA-B44 supertype (Sidney et al. 2003) , although the HLA molecules have a primary anchor at position 2 as opposed to position 3.
For Mamu-A7*01:03, the analysis revealed a motif which parallels the one observed for HLA-A*01:01 (Kondo et al. 1997) . Positions 2 and 3 were identified as primary anchor positions. At position 2, residues S, V, I, T, A, and L were preferred. At position 3, M and Q were preferred, while I was tolerated. The C terminus was classified as a dominant secondary anchor, with L, W, I, M, V, and F being tolerated. Position 1 was also designated as a dominant secondary anchor (Fig. 2) .
The current analysis also revealed that two of the MHC class I molecules were associated with an HLA-A3-like motif . In the case of Mamu-B*066:01, the C terminus primary anchor position was associated with a preference for K, R, and Y. Positions 1, 2, and 3 were identified as dominant secondary anchors positions. For Mamu-B*090:01, the preferred positions and residues were similar to those observed in the case of Mamu-B*066:01. Specifically, the C terminus was the primary anchor position, with a preference for the positively charged residues R and K. Positions 2 and 3 were identified as weak secondary anchors (Fig. 2) .
Most interestingly, two of the Chinese rhesus MHC class I molecules were associated with an HLA-B27-like motif (Sette and Sidney 1999) . In the case of Mamu-A2*01:02, position 2 and the C terminus were identified as the primary anchor positions. Histidine (H) was dominant at position 2, and the aromatic residues Y and W were preferred at the C terminus (with M, L, and F being tolerated) (Fig. 2) . For Mamu-B*010:01, position 2 and the C terminus were also identified as primary anchors. Similar to Mamu-A2*01:02, H was the dominant residue at position 2, while A was tolerated. At the C terminus, the aromatic residue F and aliphatic residues M, L, and I were preferred. Weak secondary anchors were identified as positions 7 and 8 (Fig. 2) .
The peptide-binding motifs of all six newly characterized Chinese rhesus macaque class I molecules overlap with HLA class I supertypic motifs
The addition of these alleles yields a total of 12 MHC class I alleles that have been characterized for Chinese rhesus macaques. Out of these 12 alleles, 11 have peptide-binding motifs that overlap those defined for several HLA class I supertype ( Table 2 ). The HLA analogy spans the HLA-A1 (one Chinese rhesus macaque allele), HLA-A2 (one allele), HLA-A3 (three alleles), HLA-B7 (one allele), HLA-B27 (three alleles), and HLA-B44 (two alleles) supertypes. This is in contrast to the case with Indian rhesus macaques, where only 7 of the 13 alleles characterized to date have motifs that could be classified as analogous with HLA supertype alleles. Also, only four HLA supertypes are covered by the Indian rhesus macaque alleles: HLA-A1 (one allele), HLA-B27 (three alleles), HLA-B44 (two alleles), and HLA-B58 (one allele).
Low cross-reactivity between peptide-binding repertoires of Chinese MHC class I analogs of HLA-B27 and HLA-B27
The HLA-B27 motif is characterized as preferring positively charged residues at position 2 and hydrophobic or aliphatic residues at the C terminus. Two of the macaque MHC class I alleles described herein, Mamu-A2*01:02 and Mamu-B*010:01, possess comparable motifs. To evaluate whether these motif similarities would also correspond to overlapping repertoires, we evaluated the capacity of both molecules to bind a panel of previously characterized HLA-B27 epitopes. It was found that Mamu-B*010:01 bound nine of HLA-B27 epitopes (33 %) with an affinity of 500 nM or better (Table 3) , representing cross-reactivity similar to that seen among various HLA supertypes (Greenbaum et al. 2011) . At the same time, however, Mamu-A2*01:02 was associated with a much lower level of cross-reactivity and bound only three of the HLA-B27 peptides (11 %) with an affinity of 500 nM or better. These data highlight that, while the motif associated with these molecules are remarkably similar to HLA-B27, the corresponding peptide-binding repertoires may be more divergent.
Differences in the size of the peptide repertoire associated with different Mamu MHC class I alleles Next, we determined if the PSCL-based motifs could be used to identify MHC class I molecule-specific binding peptides. The PSCL matrices derived for each allele were used to score all 9-mer sequences in the SIVmac239 proteome, as described in the "Materials and methods" section. Sequences scoring in the upper 3.0 % range (n=100) for each individual allele were synthesized and tested for their capacity to bind the corresponding MHC class I molecule. A 500-nM affinity threshold, described previously as being associated with immunogenicity (Allen et al. 2001; Loffredo et al. 2004 Loffredo et al. , 2005 Mothe et al. 2002b; Sette et al. 1994a Sette et al. , c, 2005 van der Most et al. 1998; Vitiello et al. 1996) , was utilized to define binding. The binding capacity of the predicted peptides is summarized in Table 4 . From these data, the average of the predicted peptides that bound with affinities of 50 nM or less was 12.5 % (75 peptides bound out of 600), and 33 % bound at the 500-nM level (197 peptides out 600). The actual values for the specific alleles varied substantially, however, with as few as 9 of the peptides binding to Mamu-A2*01:02 at the 500-nM level and as many as 72 of the peptides binding to Mamu-B*066:01 at the 500-nM level. At the 50-nM level, the same 2 alleles represented the extremes of the variability spectrum: 2 for Mamu-A2*01:02 and 42 for Mamu-B*066:01.
To assess whether the lower number of peptides identified for certain alleles, such as Mamu-A2*01:02 and Mamu-A1*022:01, was due to lower predictive capacity of the respective algorithms or whether they were reflective of the inherent size of the peptide repertoire, the number of binders was plotted as a function of the prediction ranking (Fig. 3a for binders at the 50-nM level and Fig. 3b for binders at the 500-nM level). In both cases, most binders were identified in the highest-ranking predictions. Prediction efficacy leveled off after the top 50 peptides, corresponding to the top 2 %. At the 500-nM level for these 2 alleles, 86 % of binding peptides (19 of 22) were identified in the highest-ranking peptides (top 2 %) (Fig. 3) . Similarly, at the 50-nM level for the same two alleles, 100 % of binding peptides (six out of six) were identified within the top 2 % of predictions (Fig. 3) . These data indicate and tolerated residues displayed. Dominant (green) and weak (yellow) secondary anchor positions are also highlighted. Residues that are associated with deleterious effects on binding capacity (>100-fold decrease), when present at a given position, are indicated by red font that the lower number of peptides identified for Mamu-A2*01:02 and Mamu-A1*022:01 was not due to a limited predictive capacity of the algorithms, but rather to the smaller size of the available peptide repertoire. Comparing data generated for the Chinese rhesus alleles characterized herein to previous studies utilizing the same methodology (italicized in the legend of Fig. 3 ), a similar variation in peptide-binding repertoire was noted (Fig. 3) . The two of the three alleles associated with lower repertoire size (Mamu-A2*01:02 and Mamu-B*010:01) are also the ones associated with HLA-B27-like motifs. Conversely, Mamu-B*066:01, Mamu-B*083:01, and Mamu-B*090:01, which were associated with higher frequencies of binders with affinities <500 nM (Fig. 3b) , were all associated with HLA-A3-like motifs. Specifically, Mamu-B*090:01 is not one of the best MHC class I molecules for binding predicted peptides as it had only eight binders <50 nM (Table 4) . But, as shown in Fig. 3b , we identified an additional 40 binders between 50 and 500 nM, for a total of 48 binders. This total places Mamu-B*090:01 third overall in its ability to bind predicted peptides.
Discussion
In this study, we report the peptide-binding motifs associated with six common Chinese-origin rhesus macaque MHC class I molecules. With the characterization of these alleles along with previously characterized Chinese-origin MHC class I alleles, we have determined motifs accounting for approximately 60 % of the MHC class I genes expressed in captive-bred Chinese rhesus macaques. Chinese rhesus macaques are unlike their Indian rhesus macaques in that no specific allele is present with >9 % phenotypic frequency (Solomon et al. 2010) . Therefore, characterization of a substantial number of alleles is required to achieve appreciable coverage.
Through the process of characterizing the most common alleles, we determined that many of the MHC class I alleles For each of the Chinese rhesus MHC class I molecules examined in the present study, as well as several others previously characterized, the cumulative number of binders identified from the predicted top 3 % SIV-derived peptides was plotted as a function of the prediction ranking. Shown is the cumulative number of peptides binding with affinities of a 50 nM or better or b 500 nM or better. Alleles characterized in previous studies are indicated by italicized font. The HLA supertype associated with each allele is indicated; G@p2 indicates an allele that was associated with a unique motif requiring the presence of glycine at the second position (Sette et al. 2012) in Chinese rhesus macaques are analogous to HLA supertypic alleles. In this study, we determined that Mamu-A7*01:03 possesses an HLA-A1-like motif, two additional macaque alleles are HLA-A3-like (Mamu-B*066:01 and Mamu-B*090:01), and Mamu-B*087:01 is HLA-B44-like. Additionally, both Mamu-A2*01:02 and Mamu-B*010:01 are HLA-B27-like. This data should be interpreted in the context of previous studies that had characterized Mamu-A1*022:01 (HLA-B7-like), Mamu-A1*026:01 (HLA-A2-like), and Mamu-B*083:01 (HLA-A3-like) (Solomon et al. 2010; Southwood et al. 2011) .
The identification of Mamu-A2*01:02 and Mamu-B*010:01 as having HLA-B27-like motifs is striking, given the previously described association, in Indian macaques, of the HLA-B27-like alleles Mamu-B*003:01 and Mamu-B*008:01 (Loffredo et al. 2009 ) with elite controller status. Even if it is true that, in HIV infection, some of the most protective alleles have HLA-B27 supertype properties (i.e., HLA-B*27:05), it is not true for all of them (for example, HLA-B*15:03) (McMichael and Jones 2010). In the context of the Chinese macaque HLA-B27-like alleles, while the motifs of these various alleles are similar, the exact epitopes identified in each context do not appear to cross-react between the human and macaque MHC class I molecules. It remains to be determined whether Chinese macaque HLA-B27-like alleles confer protection in the context of SIV infection. It is possible that other alleles have a protective role in the context of Chinese rhesus macaque SIV infection. Indeed, in HIV infection, HLA-B*27:05 is not the only protective allele, as other alleles, such as HLA-B*57, have been associated with long-term nonprogression of the disease (Chen et al. 2012; Matthews et al. 2012) . While the focus of the present study has been on MHC class I alleles, it is also possible that other genes play a significant role in disease progression.
A total of 11 out of 12 of Chinese macaque MHC class I molecules studied to date appear homologous to HLA supertype molecules. By comparison, only 7 out of 13 of Indian macaque MHC class I molecules studied to date appear homologous to HLA supertype molecules. Thus, it is possible to hypothesize that the MHC/peptide-binding properties of Chinese rhesus macaque MHC class I alleles are more similar to the features of human MHC class I molecules. If this is indeed the case, this would suggest that they may represent a better model of HIV infection than the more extensively studied Indian macaques. However, before reaching this conclusion, several factors need to be considered.
First, there are several alleles that are present in both Indian and Chinese rhesus macaques that are of interest from an HLA analogy perspective. Specifically, Mamu-B*001:01:02 and Mamu-B*003:01 are present in both sets of animals with somewhat different phenotypic frequencies. Mamu-B*001:01:02 is present in 5.8 % of Chinese rhesus macaques (Solomon et al. 2010 ), but 26 % of Indian rhesus macaques ). This allele is of further interest in that it does not seem to present peptides from SIV in Indian rhesus macaques . Mamu-B*003:01, an HLA-B27-like allele, is also present in 5.8 % of Chinese rhesus macaques (Solomon et al. 2010 ), yet is only present in 0.7 % of Indian rhesus macaques (Kaizu et al. 2007 ). These allele frequency differences can partially be explained by the continued importation of Chinese rhesus macaques and the ban on importation of Indian rhesus macaques (Southwick and Siddiqi 1988) . A further consideration is that, in Indian rhesus macaques, there are several alleles which are expressed at higher frequencies, such as Mamu-A1*001:01 (22.1 %; Kaizu et al. 2007 ) and Mamu-A1*002:01 (20.2 %; Kaizu et al. 2007 ). These two alleles, combined with Mamu-B*001:01:02, illustrate that, in Indian rhesus macaques, frequencies for specific alleles are much higher than any allele identified in Chinese rhesus macaques thus far. Nevertheless, allele selection for specific studies needs to surpass solely phenotypic frequencies and extend into functional properties such as epitope presentation and/or role in disease. Hence, more functional studies directly addressing potential cross-reactivity are clearly necessarily required.
While our results indicate a higher incidence of MHC alleles with HLA supertype characteristics in the Chinese macaque population compared to the Indian population, this observation should be interpreted with caution. First, based on the limited data available, the trend is just approaching statistical significance (exact Fisher test p value of 0.07). Furthermore, most alleles of the Mamu-A2 locus likely share the same characteristics as Mamu-A2*01:02, as this locus is oligomorphic. In fact, Mamu-A2*01:01 from Indian rhesus macaques possess the same amino acid sequence as Mamu-A2*01:02 throughout the alpha 1, 2, and 3 extracellular domains (Robinson et al. 2013) . As ∼60 % of Indian rhesus macaques possess at least one haplotype carrying the Mamu-A2 locus, the HLA-B27 supertype property should be rather frequent among Indian rhesus macaques. Indeed, several HLA supertypes present in the Chinese rhesus macaque population that were not also observed in the Indian population may have been missed in the latter group solely because of the limited number of alleles characterized to date. However, since the alleles studied were selected on the basis of phenotypic frequency, the results should be representative of the most frequently encountered binding specificities. Future analyses of data relating to additional MHC class I alleles, perhaps using hierarchical clustering analyses (Greenbaum et al. 2011) , or alternative prediction strategies probing MHC/peptide specificities (Hoof et al. 2009 ) will address these issues in more detail.
Our study also provides predictive algorithms to assist in the identification of epitopes restricted by MHC class I molecules expressed in Chinese rhesus macaques. The method utilized, based on PSCL matrices, was previously successfully applied to the definition of quantitative motifs for Mamu-A1*022:01, Mamu-A1*026:01, Mamu-B*083:01, and Mamu-B*039:01 (Sette et al. 2012; Solomon et al. 2010; Southwood et al. 2011 ). In addition, we have identified SIVderived binding peptides for a total of 10 different Chinese rhesus MHC macaque class I alleles. We anticipate that these algorithms and binding data will be made available in the IEDB database and analysis resource (http://tools.iedb.org; Zhang et al. 2008) .
The data presented also highlight a significant variation in the peptide-binding repertoire associated with different allelic molecules. The basis of this phenomenon is presently unclear. However, it seems that the type of motif associated with a given allele might play a role in determining its corresponding repertoire size. For example, Mamu-B*066:01, Mamu-B*083:01, and Mamu-B*090:01, all three of which are associated with the HLA-A3 supertype, have relatively large peptide-binding repertoires, as compared to Mamu-A2*01:02 and Mamu-B*010:01, which are associated with an HLA-B27-like motif. This phenomenon may be related to the relative rarity of the amino acids comprising the corresponding motifs. For example, alleles which require the presence of relatively infrequent residues in anchor positions would be expected to have a more limited repertoire of peptides than those alleles having a less restrictive chemical specificity. The former case might be exemplified by HLA-B7, which has a narrow position 2 main anchor specificity for P, which has an amino acid frequency of about 6 % in naturally occurring protein sequences (Tsuji et al. 2010 ). The latter case may be exemplified by alleles in the HLA-A3 supertype, where K, R, Y, and H, with a collective frequency in proteins of about 17 %, are all tolerated at the C-terminal main anchor position. Future studies will address whether a similar variation in repertoire size is a general phenomenon and is associated with MHC class I molecules expressed in humans and other species.
Regardless of the evolutionary ramifications of MHC polymorphism and function, our findings have important practical implications because of the potential role of Chinese-origin rhesus macaques in biomedical research. The presence of key HLA-like specificities in the Chinese rhesus population provides the scientific community valuable tools, allowing the evaluation of disease pathogenesis and vaccine concepts, with consideration for broader human population coverage implications.
